Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 4Completed 3Terminated 2Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Conditions

Breast Neoplasms 1780Neoplasms 1500Carcinoma, Non-Small-Cell Lung 1045Prostatic Neoplasms 958Colorectal Neoplasms 882Lung Neoplasms 803Pancreatic Neoplasms 573Carcinoma, Hepatocellular 543Leukemia, Myeloid, Acute 541Stomach Neoplasms 513Ovarian Neoplasms 508Neoplasm Metastasis 499Multiple Myeloma 494Recurrence 412Melanoma 387Squamous Cell Carcinoma of Head and Neck 370Brain Neoplasms 362Uterine Cervical Neoplasms 361Head and Neck Neoplasms 356Esophageal Neoplasms 312Precursor Cell Lymphoblastic Leukemia-Lymphoma 310Lymphoma 306Endometrial Neoplasms 305Triple Negative Breast Neoplasms 299Glioblastoma 299Rectal Neoplasms 282Sarcoma 266Urinary Bladder Neoplasms 264Hematologic Neoplasms 264Colonic Neoplasms 255

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Cancers × Clear all
NCT07290088 2026-04-16

PRL3-zumab

Intra-IMMUSG Pte Ltd

Phase 2/3 Recruiting
52 enrolled

Advanced Solid Cancers

NCT07475182 2026-03-16

Exploratory Clinical Study of Targeted Activated DC and CAR-T Therapy in Advanced Solid Cancers

Hainan Cancer Hospital

Phase EARLY_PHASE1 Recruiting
10 enrolled

Advanced Solid Cancers

NCT07092748 2025-07-30

A Phase Ia/ Ib Study of HS387 in Subjects With Advanced Solid Tumors

Zhejiang Hisun Pharmaceutical Co. Ltd.

Phase 1 Recruiting
110 enrolled

Advanced Solid Cancers

NCT06710158 2025-07-29

Study of SC-102 in Patients With Advanced Solid Tumors

Tianjin ConjuStar Biologics Co., Ltd.

Phase 1 Recruiting
120 enrolled

Advanced Solid Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡